Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:glycopyrrolate
|
| gptkbp:approves |
gptkb:1980s
|
| gptkbp:brand |
gptkb:Cuvposa
gptkb:Robinul |
| gptkbp:class |
Anticholinergic
|
| gptkbp:clinical_trial |
Phase III
Management of drooling Preoperative sedation Reduction of secretions during surgery Treatment of hyperhidrosis |
| gptkbp:contraindication |
gptkb:Myasthenia_gravis
Glaucoma Urinary retention |
| gptkbp:dosage_form |
Parenteral
|
| gptkbp:duration |
4 to 6 hours
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:excretion |
Renal
|
| gptkbp:formulation |
Injectable solution
|
| gptkbp:frequency |
As needed
|
| https://www.w3.org/2000/01/rdf-schema#label |
Glycopyrrolate Injection
|
| gptkbp:indication |
Management of excessive sweating
Preoperative medication |
| gptkbp:ingredients |
gptkb:Glycopyrrolate
C19 H26 Br N O3 |
| gptkbp:interacts_with |
Antihistamines
Antidepressants Muscle relaxants |
| gptkbp:is_used_for |
Anesthesia adjunct
Reducing salivation Treating peptic ulcers |
| gptkbp:lifespan |
1.5 hours
|
| gptkbp:manager |
Intramuscular
Intravenous Injection |
| gptkbp:manufacturer |
Various manufacturers
|
| gptkbp:metabolism |
Hepatic
|
| gptkbp:packaging |
Vial
|
| gptkbp:population |
gptkb:Person
Adults |
| gptkbp:premiered_on |
Immediate
|
| gptkbp:regulatory_compliance |
Prescription only
|
| gptkbp:safety_features |
Pregnancy category C
Lactation caution |
| gptkbp:side_effect |
Dizziness
Constipation Blurred vision Dry mouth |
| gptkbp:storage |
Room temperature
|
| gptkbp:weight |
388.32 g/mol
|